Model
Edge
Alnylam Pharmaceuticals, Inc.
0001708764
Filing type
4
Filing date
Feb 28, 2023
Updated
Mar 1, 2023 ยท 9:21 AM
Copy reference
Filing
4
Statement of Changes in Beneficial Ownership